Phone No.
(780) 450-3957
Liquid natural health products can present different analytical considerations from powders, capsules and tablets because the formulation, available water, ingredient distribution, packaging and storage conditions can affect microbiological and quality behaviour.
Depending on the product and specification, relevant testing may include:
PBR Laboratories supports natural health product manufacturers, brand owners, ingredient suppliers, product developers and quality teams from Edmonton across Alberta, Western Canada and Canada.
The testing program should start with:
What is in the liquid formulation, what specification applies, and what quality decision must the laboratory result support?
PBR's documented catalogue supports microbiological testing for applicable plant/oil/edible matrices, along with selected nutritional, vitamin, mineral, contaminant and quality-testing capabilities.
Applicable products may include:
The analytical scope depends on the specific matrix.
A water-based liquid, oil-based formulation and concentrated botanical extract should not automatically receive the same analytical panel.
Liquid products may differ from dry dosage forms in areas such as:
These factors affect both sampling and interpretation.
For example, a liquid sample that has separated or settled may not accurately represent the complete product unless the sampling procedure reflects the intended analytical question.
Depending on product category and specification, microbiological testing may be relevant.
PBR's documented microbiological capabilities for applicable plant/oil/edible matrices include:
Applicable United States Pharmacopeia methods may include <61>, <62>, <2021> and <2022>, depending on the product and specification.
Related Service → Natural Health Product Microbiology Testing
The method should be selected according to the product category and microbiological requirement, not simply because the product is a liquid.
Broadly:
Microbial enumeration for applicable non-sterile products.
Specified-microorganism testing for applicable non-sterile products.
Microbial enumeration for applicable nutritional or dietary supplement products.
Specified-microorganism testing for applicable nutritional or dietary supplement products.
The correct method depends on:
Related Resource → Which USP Microbiology Method Applies to My Natural Health Product?
Liquid formulations often contain more available water than dry products, but the actual microbiological significance depends on the formulation.
The product may contain:
Therefore, the product's liquid state alone does not determine its microbiological risk.
A stronger question is: What properties of this formulation influence microbial growth or survival?
PBR's catalogue documents water activity testing for applicable plant/oil/edible matrices.
However, water activity is not automatically required for every liquid natural health product.
It should be considered where the value helps answer a defined formulation, quality or stability question.
This follows PBR's decision-first standard: use the test because it supports a real decision, not simply because it is available.
pH can be an important quality characteristic for some liquid formulations.
PBR's documented food-testing scope includes pH testing for applicable matrices.
For a natural health product liquid, current matrix applicability should be confirmed before publication or sample submission rather than assuming that every liquid formulation is suitable for the same pH method.
Where applicable, pH may help support investigation of:
Depending on the formulation, selected nutritional or compositional analysis may be appropriate.
PBR's documented nutritional capabilities include:
For liquid Natural Health Products, matrix suitability should be confirmed before selecting the panel.
PBR's current documented capabilities include selected vitamin testing for applicable matrices:
This does not establish a blanket capability to test every vitamin or every liquid Natural Health Product matrix.
Before submission, confirm:
PBR's documented capabilities also include selected mineral analysis such as:
The specific analyte and liquid matrix should be discussed with PBR before testing.
These are not automatically the same service.
A general compositional result may characterize the submitted product.
Medicinal-ingredient potency testing may require:
PBR should not imply that its general nutritional services automatically verify medicinal-ingredient potency for every liquid supplement.
Related Resource → Nutritional Analysis vs Medicinal Ingredient Potency Testing
Liquid products containing botanical, mineral or naturally sourced ingredients may require contaminant consideration.
PBR's catalogue documents testing for:
for applicable plant/oil/edible matrices, identified as a subcontracted service.
The need for heavy-metal testing should be based on:
Mycotoxin testing is primarily driven by the ingredients, not whether the final product is liquid.
If a liquid contains botanical or agricultural ingredients with relevant mycotoxin risk, testing may be considered at the raw-material stage and, where appropriate, in the finished product.
PBR's documented mycotoxin capabilities include:
Matrix suitability for the final liquid should be confirmed.
A liquid finished product may contain many incoming ingredients.
Raw-material testing can support:
Testing at the ingredient stage can help identify a problem before the raw material is incorporated into the final liquid.
Finished-product testing evaluates the actual manufactured liquid formulation.
It may support questions such as:
No.
The finished liquid reflects:
Raw-material testing and finished-product testing therefore answer different questions.
Related Resource → Raw Material Testing vs Finished Product Testing
A liquid sample should represent the product condition relevant to the decision.
Questions may include:
The correct sampling approach depends on the product and analytical method.
PBR's decision framework specifically warns about non-representative samples, wrong sample handling and testing a matrix or method not suited to the decision.
Ask PBR about sample requirements before submitting a liquid product.
Some liquid products may:
If the analytical target is unevenly distributed, different portions of the same container could potentially produce different results.
The sampling procedure should therefore consider whether the product needs to be homogenized according to the analytical method and product instructions.
Do not assume all liquids are naturally uniform.
Packaging can affect liquid products through:
PBR's decision framework recognizes microbiology, water activity, moisture, pH and chemistry as potential stability-related measures in applicable product studies.
For Natural Health Product liquids, the actual stability panel should be confirmed based on the product and verified PBR scope.
Depending on product suitability and study objective, analytical monitoring may include applicable:
The correct study depends on:
PBR should not claim one standard stability panel for every liquid Natural Health Product.
A failed microbiological result means the submitted sample did not meet the applicable microbiological criterion.
It does not automatically identify the contamination source.
An investigation may consider:
Follow-up testing should address the suspected source rather than automatically repeating the same finished-product sample.
Related Resource → What to Do After a Failed Natural Health Product Microbiology Result
Review:
For a liquid product, homogeneity can be especially important when interpreting composition differences.
Review:
Targeted raw-material testing may help determine whether a particular ingredient is contributing to the result.
Liquid Natural Health Product manufacturers may rely on supplier Certificates of Analysis for individual ingredients.
Independent testing can support selected verification where appropriate.
The best approach is to identify:
Related Resource → How to Verify a Supplier Certificate of Analysis
Settling or phase separation may affect sampling.
Testing should match the product and specification.
Formulation matters more than physical state alone.
These analytical objectives can be different.
Botanical and mineral ingredients can introduce different contaminant considerations.
Testing should be selected around the failure mode or quality attribute being monitored.
First determine what the follow-up testing needs to investigate.
PBR Laboratories provides liquid Natural Health Product testing support from Edmonton, Alberta.
Alberta manufacturers and quality teams can discuss:
PBR supports Natural Health Product manufacturers across Western Canada requiring applicable testing for liquid formulations.
The testing pathway should follow:
formulation → relevant risks → specification → representative sample → analytical testing → interpretation → quality decision
PBR supports Canadian companies requiring analytical testing for applicable liquid Natural Health Products.
PBR's role is to help clients connect:
the product matrix → the right analytical question → the reported result → the next decision
rather than treating laboratory testing as a disconnected list of numbers. This follows PBR's approved decision-first positioning.
Liquid Natural Health Product testing may include microbiological, selected composition, vitamin or mineral, contaminant and stability-related testing depending on the formulation and specification. Because liquids can settle or separate, sample homogeneity and representative sampling should be considered before interpreting a result as representative of a larger batch.
Depending on the formulation and specification, relevant testing may include microbiology, selected composition analysis, vitamins or minerals where applicable, heavy metals, raw-material testing and stability-related quality measurements.
PBR's documented microbiology scope includes multiple targets for applicable plant/oil/edible matrices. The specific liquid matrix and required United States Pharmacopeia method should be confirmed before submission.
Depending on the product category and specification, relevant microbiology methods may include United States Pharmacopeia <61>, <62>, <2021> and <2022>.
No. The formulation, water availability, pH, ingredients, processing and storage conditions all influence microbial behaviour.
PBR's documented capabilities include selected vitamins A, C and D for applicable matrices. The specific liquid matrix and analytical objective should be confirmed before testing.
PBR's documented capabilities include selected minerals such as calcium, iron, sodium, potassium and magnesium for applicable matrices. Matrix suitability should be confirmed.
Potentially, depending on the ingredient sources, formulation and specification. PBR's catalogue documents lead, arsenic, cadmium and mercury for applicable plant/oil/edible matrices as a subcontracted service.
Potentially, where botanical or agricultural ingredients create a relevant risk. The suitability of finished-liquid testing should be confirmed with PBR.
Some liquids may settle or separate, so the submitted portion may not represent the entire product unless the sampling method is appropriate.
No. Finished-product results also reflect formulation, processing, mixing, packaging and storage.
Potentially, where microbiological quality is relevant to the product and the study objective. The specific stability plan should be confirmed for the matrix.
Yes. PBR supports clients throughout Alberta, Western Canada and Canada.